1.
Kałwik M, Klepacz I, Mikołajczak P, et al. Anti-CD20 MONOCLONAL ANTIBODIES IN THE TREATMENT OF MULTIPLE SCLEROSIS: MECHANISMS OF ACTION, CLINICAL EFFICACY, SAFETY, AND CONTEMPORARY THERAPEUTIC PERSPECTIVES. IJITSS. 2026;4(3(51). doi:10.31435/ijitss.3(51).2026.6456